地拉罗司医保是否可以报销？

It was approved by the FDA in November 2005 for use in patients 2 years and older with chronic iron overload caused by blood transfusions. 

In December 2012, Deferasirox was approved by the European Commission for the treatment of chronic iron overload in patients aged 10 years and older with non-transfusion-dependent thalassemia (NTDT) syndrome who require chelation therapy due to contraindications or insufficiency of deferoxamine mesylate therapy. 

On January 23, 2013, the FDA approved a new indication for deferasirox for the treatment of chronic iron overload in patients aged 10 years and older with non-transfusion-dependent thalassemia (NTDT).  

In 2010, deferasirox was approved for marketing in China and is used to treat chronic iron overload caused by frequent blood transfusions (monthly administration of concentrated red blood cells ≥ 7 mL/kg) in patients with beta-thalassemia older than 6 years old. For children under 6 years old and iron overload caused by other transfusion-dependent diseases, can deferasirox be reimbursed by medical insurance?

According to Medical Companion Travel, deferasirox has not yet been officially included in medical insurance and cannot be reimbursed by medical insurance. It is a self-paid drug for patients! 

The price of Deferasirox after it was launched in China was relatively high, with a box costing about $2,000. For an ordinary person weighing 60kg, the cost of taking deferasirox for a month exceeds about $24,000. It is difficult for ordinary families to accept this price!  

Fortunately, there are also foreign versions for everyone to choose from. Novartis of Switzerland imported deferasirox to India. The specification is 400mg*30 tablets/box, and the price is about $700.  

The specification of Deferasirox produced by Indian pharmaceutical factory is 500*30 tablets/box, and the price is about 500$. Due to the fluctuation of exchange rate, the price will be different. Please consult the medical companion for the specific price!  

Regarding the use of deferasirox by special groups:

1. For pregnant women, children under 6 years old, the elderly, and pregnant women, deferasirox should be used with caution;

2. Deferasirox should not be used in children under 2 years old;

3. It is prohibited for those who are allergic to and related ingredients.